跳至主要内容
临床试验/JPRN-UMIN000042226
JPRN-UMIN000042226招募中未知

Prospective observational study of the efficacy and safety of carbon-ion radiotherapy followed by Nivolumab for primary mucosal malignant melanoma of the head and neck - iROCK-2001H

Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization0 个研究点目标入组 34 人开始时间: 2020年10月26日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients with interstitial pneumonia, drug-induced interstitial lung disease or clinically active interstitial lung disease on chest CT scan 2)Patients with autoimmune disorders 3)Known allergy to compounds of similar chemical or biologic composition to Nivolumab 4)Pregnant or lactating females 5)Patients in which the physician decides that participation in the study is unsuitable

研究者

发起方
Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization

相似试验